News Conference News European Congress on Obesity 2025 App-Based Support Aids Weight Loss With Semaglutide, Studies Show Michael O'Riordan May 13, 2025
News Conference News European Congress on Obesity 2025 Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5 Michael O'Riordan May 12, 2025
News Daily News Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study Todd Neale May 09, 2025
News Daily News Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention Michael O'Riordan May 07, 2025
News Daily News AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease Caitlin E. Cox May 06, 2025
News Daily News HDL Cholesterol Levels May Sway Statin Decisions in Primary Prevention Michael O'Riordan May 02, 2025
News Daily News Access to GLP-1 Drugs Unequal for US Patients With Obesity Caitlin E. Cox May 01, 2025
News Conference News CX Symposium 2025 Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI L.A. McKeown April 30, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2025 Caitlin E. Cox April 30, 2025
News Conference News HRS 2025 GLP-1 Drugs May Have Role in Secondary Prevention of AF Todd Neale April 28, 2025
News Daily News Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds Michael O'Riordan April 25, 2025
News Conference News CX Symposium 2025 Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices L.A. McKeown April 23, 2025
News Daily News PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients Todd Neale April 23, 2025
News Daily News Black Adults Face CV Mortality Beyond Their Predicted Risk Caitlin E. Cox April 18, 2025
News Daily News Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says Caitlin E. Cox April 17, 2025
News Daily News High BMI Before Pregnancy Tied to Greater CVD Risk Later in Life L.A. McKeown April 14, 2025
News Daily News Weekend Warriors Also See Mortality Benefits With Exercise Michael O'Riordan April 10, 2025
News Conference News ACC 2025 ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a) L.A. McKeown April 10, 2025